Cardiometabolic Clinical Trial Sites, Led by Practicing Physicians
Bringing obesity, metabolic disease, and cardiovascular expertise to Tekton sites supporting cardiometabolic research.
The Tekton Cardiometabolic Team brings investigator expertise and coordinated site support to obesity, metabolic dysfunction-associated steatohepatitis (MASH), cardiovascular risk, and related metabolic studies. Physician input on eligibility, comorbidities, and participant access informs site recommendations and study preparation.
Featured Cardiometabolic Investigators
Lacy Anderson, MD
Lacy Anderson, MD, is a board-certified family medicine physician and Principal Investigator with 20+ years in family medicine, experience conducting 10+ clinical trials, and a strong community education platform through News 9’s Daily Dose segment.
Kyle Rickner, MD
Kyle Rickner, MD, is a board-certified family physician, Principal Investigator, and Primary Health Partners co-founder with 20+ years in clinical research and experience across 70+ clinical trials.
Brandon Alleman, MD, PhD
Brandon Alleman, MD, PhD, is a board-certified family physician, Principal Investigator, and Antioch Med co-founder with 10+ years in practice, experience conducting 10+ clinical trials, and a PhD in translational biomedicine and a certificate in biostatistics.
Jeffrey Chasteen, DO
Jeffrey Chasteen, DO, is a board-certified family physician and Principal Investigator with 20+ years in practice, experience conducting 10+ clinical trials, and broad experience across family medicine, urgent care, hospice, and palliative care.
Ashok Devatha, MD
Ashok Devatha, MD, is a board-certified family physician and Principal Investigator with 30+ years in clinical practice and 5+ years in clinical research, and a community-based practice serving the Dayton metro area.
Clinical Operations Leader
Kelli Wilson, AAS, CCRC
The Proven Site Model
The Site Partner Built to Simplify Your Next Cardiometabolic Study
A physician-led research model
Tekton works with established practicing physicians who bring clinical credibility, therapeutic experience, and trusted patient relationships to the studies they conduct.
Dedicated research staff and centralized operational support extend that clinical foundation, helping participating sites recruit appropriate populations, maintain engagement, and execute protocols consistently.
Select best-fit sites
Tekton recommends sites based on Principal Investigator experience, practice population, referral pathways, required equipment, visit burden, comorbidity requirements, competing studies, and operational readiness.
The Cardiometabolic Team provides an additional layer of investigator and operational review, helping determine whether a protocol is best served by one specialized location or a coordinated group of sites.
Coordinated startup, clear ownership
Tekton centralizes regulatory activities, budgets, site preparation, and operational coordination to provide a more consistent path from selection through activation.
Days from activation to FPI
A single point of coordination surfaces risks earlier, aligns sites around study requirements, and keeps responsibilities visible as the study moves toward FPI.
Recruitment: Activate fast, enroll early
Feasibility, physician practice populations, centralized recruitment, and site-level follow-up work together to support each study.
Tekton's Austin-based recruitment center coordinates strategy and execution across participating sites, supported by local physician referrals, community relationships, and disease-specific access.
Tekton maintains a database of more than 340,000 profiled participants, including more than 70,000 people within its cardiometabolic database.
Retention: A Tekton advantage
Retention is shaped by the everyday experience of participating in a clinical trial. Clear communication, reliable scheduling, familiar site teams, and thoughtful visit support all influence adherence and continuity.
Tekton's physician relationships and dedicated research teams provide a consistent local presence, while centralized oversight supports protocol execution.
Across completed Tekton studies, average participant retention is 95%. This is an organization-wide result.
Quality treated as an essential component of delivery
Tekton incorporates quality assurance, regulatory support, clinical data oversight, and risk management into study preparation and ongoing execution.
Central teams support protocol training, source and electronic data capture review, document management, compliance tracking, corrective actions, and inspection readiness.
This structure helps identify risks earlier, reinforce consistent processes, and protect participant safety and data integrity throughout the study.
Tekton Cardiometabolic Team Questions & Answers
Tekton evaluates studies across obesity, MASLD, MASH, hypertension, dyslipidemia, cardiovascular risk and outcomes, chronic kidney disease, type 2 diabetes, and related metabolic conditions.
Final site recommendations depend on the protocol, Principal Investigator experience, participant access, equipment requirements, and current site readiness.